Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amidotrizoic acid, also known as diatrizoic acid, is a high-osmolality, water-soluble, iodinated radiopaque contrast medium used in diagnostic imaging. It is typically administered as a mixture of its sodium and meglumine salts. The molecule contains three iodine atoms which absorb X-rays, providing the contrast necessary to visualize internal structures such as the gastrointestinal tract, urinary system, and blood vessels during X-ray and computed tomography (CT) examinations. While it has been largely superseded by low-osmolality contrast agents for intravascular use due to a higher risk of adverse reactions, it remains a standard agent for oral and rectal administration in the evaluation of gastrointestinal disorders. Laboratorios Juste (Justesa) is a significant manufacturer of the active pharmaceutical ingredient (API).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amidotrizoic acid.